A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy Participants

Condition:   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Intervention:   Drug: [14C]CCX168 Sponsor:   Amgen Completed

Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials